Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[250 Pages Report] The global farm animal drugs market size is expected to reach a valuation of US$ 17.2 Billion by the end of 2022, and further expand at a CAGR of 5.5% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 29.4 Billion by the end of 2032. Livestock animals are leading the market in terms of animals and the segment held a share of about 92.4% in 2021.
Omnivorous people are directly dependent on healthy, productive animals for their food supply and financial security, especially in low- and middle-income nations, where a high percentage of people make a living by raising animals. The Health for Animals Organization estimates that 1.3 billion individuals keep livestock worldwide (2021). As a result, controlling and preventing animal diseases is essential to achieving sustainable development goals and is a worldwide public benefit.
In addition, antibiotics are frequently used to treat sick animals. Failure to follow drug withdrawal periods in farm animals leads to the production of contaminated products and raises concerns about their safety when consumed by humans. Over certain maximum levels of antibiotic residue, items are regarded unfit for ingestion and should be thrown away in a manner that minimizes the risk of environmental contamination.
Humans can contract antimicrobial-resistant bacteria from food animals either directly or indirectly through contaminated environments, compromised foods, or direct contact with animals. These factors are projected to compel pharmaceutical companies to develop innovative farm animal drugs.
Attributes | Key Statistics |
---|---|
Farm Animal Drugs Market Estimated Valuation (2022E) | US$ 17.2 Billion |
Projected Market Valuation (2032F) | US$ 29.4 Billion |
Value-based CAGR (2022 to 2032) | 5.5% |
Collective Value Share: Top 5 Countries | 51.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for farm animal drugs held approximately 54.9% of the global veterinary medicine market, which was worth ~US$ 29.4 Billion in 2021. Sales of farm animal drugs expanded at a CAGR of 5.8% from 2012 to 2021 owing to rising advancements in the field of zoonotic disease diagnostics.
Cross-sectoral cooperation is prioritized in order to control risks and effects from the interface between people, animals, and the environment to enhance global health security. A key element in reaching this goal is making sure that veterinary medications are of high quality. Veterinary medicinal items that are substandard and falsified (SF) will logically have a negative impact on food security, farming & animal trading networks, and agricultural production.
Limited active pharmaceutical ingredient (API) concentrations in SF antibiotics or low bioavailability, as seen by poor dissolving, increase the risk of sub-therapeutic plasma levels. Antimicrobial resistance (AMR), which can be transmitted to people through contact with animals, food, or their environment, may be selected for by pathogens that "see" suboptimal drug levels in animals.
Farmers have been under constant pressure to produce more food, but in limited spaces, in an effort to meet the rising food demand, which is being fuelled by rapid population growth, urbanization, and growing income. Additionally, antibiotics are present in animal foods. They are introduced to animal feeds in little (sub-therapeutic) amounts to encourage growth, but this can result in the rise of AMR bacteria. Many regions, notably the European Union, have outlawed the use of growth boosters.
Long hospital admissions, rising mortality, reduction in the protection provided to patients needing surgery, and higher treatment expenses are some of the negative effects of infection associated with AMR bacteria. With the high demand for safe food for consumption, the market for farm animal drugs is expected to witness growth at a CAGR of 5.5% during the forecast period from 2022 to 2032.
Controlled-release (CR) technology has a lot of potential in the veterinary sector. The welfare of animals (reduced strain from restrictions and handling needed for more regular dosing of conventional dosage forms), caregiver or veterinarian convenience, and cost-effectiveness are some of the primary drivers for the development of a controlled and/or prolonged-release system in veterinary medicine.
Contrary to the delivery of medicine in drinking water or food, controlled-release systems are not only easier to use than repeat-injection dosing but also allow for the measurement of the drug's dosage. When compared to dosage via oral or injectable routes, topical administration for local or systemic effects frequently offers additional advantages such as reduced handling during administration. Thus, the emergence of the controlled release technology is set to provide traction to the overall growth in the farm animal drugs market during the forecast period.
The National Regulatory Authorities (NRAs) are still underfunded in many low-and middle-income countries (LMICs). Even if the World Health Organization's (WHO) Global Benchmarking of Regulatory Systems can currently revolutionize the way regulatory strengthening is directed, significant investments will be required to achieve an adequate level of regulatory maturity globally. The relatively heavy weight of the aforementioned issues in LMICs is mostly attributable to weak regulatory frameworks, limited resources, inadequate infrastructure, and a lack of skilled employees.
It is essential to evaluate the efficacy of medications using strict standards and to keep an eye on their sensible usage, including in the veterinary industry, in order to determine the severity and scope of the issue & to guarantee the provision of high-quality healthcare services. Owing to the aforementioned factors, the global farm animal drugs market may be hampered in the upcoming decade.
“Surging Meat Exports from the USA to Spur Sales of Antibiotics for Livestock”
The USA dominates the North American region and generated a farm animal drugs market share of about 56.5% in 2021. As per FMI, the country is expected to continue to experience the same growth rate throughout the forecast period. The rising prevalence of various animal diseases brought on by increased globalization, high demand for meat exports from the USA, and antibiotic resistance in animals are projected to encourage key players to develop innovative farm animal drugs in the country.
“Strict Rules Governing Antibiotics Used for Animals to Push Growth in Germany”
Germany held a share of about 2.7% in the global farm animal drugs market in 2021. One aspect that is affecting antibiotic sales in the country is stringent legislation governing the use of antibiotics for increasing the productivity of farm animals. The majority of livestock production in Germany is highly industrialized and modernized, and the percentages of production that employ various biosecurity measures & disease-threat reduction techniques have been rising. Regulations or consumer pressures have pushed the nation to embrace disease-reduction strategies, which would boost the German farm animal drugs market.
“Expansion of the Indian Dairy Sector to Boost Demand for Antibiotics for Farm Animals”
India held approximately 3.8% of the share of the global farm animals market in 2021. Livestock production, especially the dairy industry, is crucial for the food and nutritional security of various communities in India. It also provides a living for many farmers and supports the nation's economy. Antimicrobial resistance (AMR) is a significant public health concern, and India is a country with high consumption of antibiotics. This factor would thus propel the Indian farm animal drugs market in the upcoming decade.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“High Prevalence of Zoonotic Diseases to Drive Sales of Anti-infective Medications”
By product, the anti-infective segment held a share of around 36.9% in the global farm animal drugs market in 2021. The segment is expected to hold the largest market share in the next decade owing to rising concerns regarding animal health, the surging prevalence of zoonotic diseases, as well as transmission of these diseases to humans from animals.
“Antibiotics for Livestock to Gain Impetus with High Demand for Meat Products”
By animal, the livestock animals segment held the highest farm animal drugs market share of about 92.4% in 2021. With increasing reliance on animal and dairy products globally, there is an urgent need to prevent contamination of meat products, which would thus propel the livestock animals segment in the market. Disease prevention and control, as well as the development of novel formulations for producing safe and quality foods, are further expected to foster this segment.
“Large Animal Antibiotics to Be Provided through the Oral Route of Administration”
The oral route of administration segment held the highest market share of about 41.3% in 2021. In cattle, poultry, and pigs, the oral mode of administration is most frequently employed. Premixes, drinking water additives, tablets, capsules, drenches, licks, boluses, and pastes are some of the common examples of oral formulations. The segment is expected to hold a high market share over the forecast period owing to its ease of administration.
“Antibiotics for Farm Animals to Be Made Available in Veterinary Hospitals”
Veterinary hospitals held a revenue share of about 45.6% in 2021 in the global farm animal drugs market. With the presence of skilled professionals, greater awareness about the health & management of livestock animals, and favorable government incentives, veterinary hospitals hold a dominant market share based on distribution channels in the global farm animal drugs market.
Key players present in the global farm animal drugs market are focusing on expanding their product portfolios by engaging in acquisitions and mergers with local companies. A few other key players are investing huge sums in research and development activities to come up with novel formulations for maintaining the overall health of farm animals, as well as for increasing the quality of dairy products and meats while processing.
Some of the recent industry developments in the global market are:
Attribute | Details |
---|---|
Estimated Market Size (2022) | US$ 17.2 Billion |
Projected Market Valuation (2032) | US$ 29.4 Billion |
Value-based CAGR (2022 to 2032) | 5.5% |
Forecast Period | 2012 to 2021 |
Historical Data Available for | 2022 to 2032 |
Market Analysis | Value (US$ Billion) |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA) |
Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa |
Key Market Segments Covered | Product, Route of Administration, Animal, Distribution Channel, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The global farm animal drugs market was valued at around US$ 16.1 Billion in 2021.
Sales in the farm animal drugs market are set to witness a CAGR of 5.5% and the market is to be valued at around US$ 29.4 Billion by 2032.
The global farm animal drugs market grew at 5.8% CAGR from 2012 to 2021.
The USA, Canada, China, the UK, and Russia are expected to surge the demand for farm animal drugs. Together, these countries are currently holding 51.8% of the market share.
The USA accounted for around 56.5% of the share in the North America farm animal drugs market in 2021.
Bayer AG, Boehringer Ingelheim GmbH, and Zoetis, Inc. are the top three manufacturers in the farm animal drugs market.
The China farm animal drugs market held a share of about 5.7% in 2021.
The Japan farm animal drugs market held a share of about 9.2% in 2021.
The German farm animal drugs market is set to hold a share of around 2.7%.
Key players operating in the farm animal drugs market include Bayer AG, Boehringer Ingelheim GmbH, Zoetis, Inc., Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health (Sub. Eli Lilly), Merck Animal Health, Virbac SA, Vetoquinol SA, and Intas Animal Health among others.
1. Executive Summary | Farm Animal Drugs Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Drug Innovation / Development Trends 4. Key Success Factors 4.1. Promotional Strategies Adopted by Key Manufacturers 4.2. Key Regulations 4.3. Reimbursement Scenario 4.4. PESTEL Analysis 4.5. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Veterinary Medicine Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Technological Developments 5.2.2. Introduction of Novel Formulations 5.2.3. Rising Cases of Zoonotic Diseases 5.2.4. Demand for Infection-Free Meat and Dairy Products 5.2.5. Government Regulations 5.2.6. Growing Incidence of Food-Borne Infections 5.2.7. Rising Demand for Quality Pharmaceuticals 5.2.8. Increasing Research and Development Activities 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Animal 6.1.3. By Route of Administration 6.1.4. By Distribution Channel 6.1.5. By Country 6.2. 2021 Market Scenario 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer-Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Billion) Analysis 2012 to 2021 and Forecast, 2022 to 2032 8.1. Historical Market Value (US$ Billion) Analysis, 2012 to 2021 8.2. Current and Future Market Value (US$ Billion) Projections, 2022 to 2032 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Billion) Analysis By Product, 2012 to 2021 9.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Product, 2022 to 2032 9.3.1. Anti-Infective 9.3.2. Parasiticides 9.3.2.1. Endo-parasiticides 9.3.2.2. Ecto-parasiticides 9.3.2.3. Endectocides 9.3.3. Anti-Inflammatory 9.3.4. Anesthetics 9.3.5. Analgesics 9.3.6. Hormones & Related Product 9.3.7. Others 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Animal 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Billion) Analysis By Animal, 2012 to 2021 10.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Animal, 2022 to 2032 10.3.1. Livestock Animals 10.3.1.1. Ruminants 10.3.1.2. Swine 10.3.1.3. Poultry 10.3.2. Equine 10.4. Market Attractiveness Analysis By Animal 11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Route of Administration 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Billion) Analysis By Route of Administration, 2012 to 2021 11.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Route of Administration, 2022 to 2032 11.3.1. Oral 11.3.2. Parenteral 11.3.3. Topical 11.3.4. Others 11.4. Market Attractiveness Analysis By Route of Administration 12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Distribution Channel 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Billion) Analysis By Distribution Channel, 2012 to 2021 12.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Distribution Channel, 2022 to 2032 12.3.1. Veterinary Hospitals 12.3.2. Veterinary Clinics 12.3.3. Pharmacies and Drug Stores 12.3.4. Others 12.4. Market Attractiveness Analysis By Distribution Channel 13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Billion) Analysis By Region, 2012 to 2021 13.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Region, 2022 to 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2012 to 2021 14.3. Current and Future Market Size (US$ Billion) Analysis & Forecast By Market Taxonomy, 2022 to 2032 14.3.1. By Country 14.3.1.1. The USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Animal 14.3.4. By Route of Administration 14.3.5. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Animal 14.4.4. By Route of Administration 14.4.5. By Distribution Channel 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country-Level Analysis & Forecast 14.8.1. The USA Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast By Market Taxonomy 14.8.1.2.1. By Country 14.8.1.2.2. By Product 14.8.1.2.3. By Animal 14.8.1.2.4. By Route of Administration 14.8.1.2.5. By Distribution Channel 14.8.2. Canada Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast By Market Taxonomy 14.8.2.2.1. By Country 14.8.2.2.2. By Product 14.8.2.2.3. By Animal 14.8.2.2.4. By Route of Administration 14.8.2.2.5. By Distribution Channel 15. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2012 to 2021 15.3. Current and Future Market Size (US$ Billion) Analysis & Forecast By Market Taxonomy, 2022 to 2032 15.3.1. By Country 15.3.1.1. Mexico 15.3.1.2. Brazil 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.1.4.1. By Country 15.3.1.4.2. By Product 15.3.1.4.3. By Animal 15.3.1.4.4. By Route of Administration 15.3.1.4.5. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Animal 15.4.4. By Route of Administration 15.4.5. By Distribution Channel 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country-Level Analysis & Forecast 15.8.1. Mexico Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast By Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Animal 15.8.1.2.3. By Route of Administration 15.8.1.2.4. By Distribution Channel 15.8.2. Brazil Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast By Market Taxonomy 15.8.2.2.1. By Country 15.8.2.2.2. By Product 15.8.2.2.3. By Animal 15.8.2.2.4. By Route of Administration 15.8.2.2.5. By Distribution Channel 15.8.3. Argentina Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast By Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By Animal 15.8.3.2.3. By Route of Administration 15.8.3.2.4. By Distribution Channel 16. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2012 to 2021 16.3. Current and Future Market Size (US$ Billion) Analysis & Forecast By Market Taxonomy, 2022 to 2032 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. The UK 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Russia 16.3.1.8. Rest of Europe 16.3.2. By Product 16.3.3. By Animal 16.3.4. By Route of Administration 16.3.5. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Animal 16.4.4. By Route of Administration 16.4.5. By Distribution Channel 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country-Level Analysis & Forecast 16.8.1. Germany Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast By Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Animal 16.8.1.2.3. By Route of Administration 16.8.1.2.4. By Distribution Channel 16.8.2. Italy Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast By Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Animal 16.8.2.2.3. By Route of Administration 16.8.2.2.4. By Distribution Channel 16.8.3. France Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast By Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Animal 16.8.3.2.3. By Route of Administration 16.8.3.2.4. By Distribution Channel 16.8.4. The UK Market Analysis 16.8.4.1. Introduction 16.8.4.2. Market Analysis and Forecast By Market Taxonomy 16.8.4.2.1. By Product 16.8.4.2.2. By Animal 16.8.4.2.3. By Route of Administration 16.8.4.2.4. By Distribution Channel 16.8.5. Spain Market Analysis 16.8.5.1. Introduction 16.8.5.2. Market Analysis and Forecast By Market Taxonomy 16.8.5.2.1. By Product 16.8.5.2.2. By Animal 16.8.5.2.3. By Route of Administration 16.8.5.2.4. By Distribution Channel 16.8.6. BENELUX Market Analysis 16.8.6.1. Introduction 16.8.6.2. Market Analysis and Forecast By Market Taxonomy 16.8.6.2.1. By Product 16.8.6.2.2. By Animal 16.8.6.2.3. By Route of Administration 16.8.6.2.4. By Distribution Channel 16.8.7. Russia Market Analysis 16.8.7.1. Introduction 16.8.7.2. Market Analysis and Forecast By Market Taxonomy 16.8.7.2.1. By Product 16.8.7.2.2. By Animal 16.8.7.2.3. By Route of Administration 16.8.7.2.4. By Distribution Channel 17. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2012 to 2021 17.3. Current and Future Market Size (US$ Billion) Analysis & Forecast By Market Taxonomy, 2022 to 2032 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Animal 17.3.4. By Route of Administration 17.3.5. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Animal 17.4.4. By Route of Administration 17.4.5. By Distribution Channel 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country-Level Analysis & Forecast 17.8.1. China Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast By Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Animal 17.8.1.2.3. By Route of Administration 17.8.1.2.4. By Distribution Channel 17.8.2. Japan Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast By Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Animal 17.8.2.2.3. By Route of Administration 17.8.2.2.4. By Distribution Channel 17.8.3. South Korea Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast By Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Animal 17.8.3.2.3. By Route of Administration 17.8.3.2.4. By Distribution Channel 18. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2012 to 2021 18.3. Current and Future Market Size (US$ Billion) Analysis & Forecast By Market Taxonomy, 2022 to 2032 18.3.1. By Country 18.3.1.1. India 18.3.1.2. Indonesia 18.3.1.3. Malaysia 18.3.1.4. Thailand 18.3.1.5. Rest of South Asia 18.3.2. By Product 18.3.3. By Animal 18.3.4. By Route of Administration 18.3.5. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Animal 18.4.4. By Route of Administration 18.4.5. By Distribution Channel 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country-Level Analysis & Forecast 18.8.1. India Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast By Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Animal 18.8.1.2.3. By Route of Administration 18.8.1.2.4. By Distribution Channel 18.8.2. Indonesia Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast By Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Animal 18.8.2.2.3. By Route of Administration 18.8.2.2.4. By Distribution Channel 18.8.3. Malaysia Market Analysis 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast By Market Taxonomy 18.8.3.2.1. By Product 18.8.3.2.2. By Animal 18.8.3.2.3. By Route of Administration 18.8.3.2.4. By Distribution Channel 18.8.4. Thailand Market Analysis 18.8.4.1. Introduction 18.8.4.2. Market Analysis and Forecast By Market Taxonomy 18.8.4.2.1. By Product 18.8.4.2.2. By Animal 18.8.4.2.3. By Route of Administration 18.8.4.2.4. By Distribution Channel 19. Oceania Market 2012 to 2021 and Forecast 2022-2032 19.1. Introduction 19.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2012 to 2021 19.3. Current and Future Market Size (US$ Billion) Analysis & Forecast By Market Taxonomy, 2022 to 2032 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Animal 19.3.4. By Route of Administration 19.3.5. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Animal 19.4.4. By Route of Administration 19.4.5. By Distribution Channel 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 19.7. Country-Level Analysis & Forecast 19.7.1. Australia Market Analysis 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast By Market Taxonomy 19.7.1.2.1. By Product 19.7.1.2.2. By Animal 19.7.1.2.3. By Route of Administration 19.7.1.2.4. By Distribution Channel 19.7.2. New Zealand Market Analysis 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast By Market Taxonomy 19.7.2.2.1. By Product 19.7.2.2.2. By Animal 19.7.2.2.3. By Route of Administration 19.7.2.2.4. By Distribution Channel 20. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032 20.1. Introduction 20.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2012 to 2021 20.3. Current and Future Market Size (US$ Billion) Analysis & Forecast By Market Taxonomy, 2022 to 2032 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. South Africa 20.3.1.4. North Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Animal 20.3.4. By Route of Administration 20.3.5. By Distribution Channel 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Animal 20.4.4. By Route of Administration 20.4.5. By Distribution Channel 20.5. Market Trends 20.6. Key Market Participants - Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 20.8. Country-Level Analysis & Forecast 20.8.1. GCC Countries Market Analysis 20.8.1.1. Introduction 20.8.1.2. Market Analysis and Forecast By Market Taxonomy 20.8.1.2.1. By Product 20.8.1.2.2. By Animal 20.8.1.2.3. By Route of Administration 20.8.1.2.4. By Distribution Channel 20.8.2. Turkey Market Analysis 20.8.2.1. Introduction 20.8.2.2. Market Analysis and Forecast By Market Taxonomy 20.8.2.2.1. By Product 20.8.2.2.2. By Animal 20.8.2.2.3. By Route of Administration 20.8.2.2.4. By Distribution Channel 20.8.3. South Africa Market Analysis 20.8.3.1. Introduction 20.8.3.2. Market Analysis and Forecast By Market Taxonomy 20.8.3.2.1. By Product 20.8.3.2.2. By Animal 20.8.3.2.3. By Route of Administration 20.8.3.2.4. By Distribution Channel 20.8.4. North Africa Market Analysis 20.8.4.1. Introduction 20.8.4.2. Market Analysis and Forecast By Market Taxonomy 20.8.4.2.1. By Product 20.8.4.2.2. By Animal 20.8.4.2.3. By Route of Administration 20.8.4.2.4. By Distribution Channel 21. Market Structure Analysis 21.1. Market Analysis By Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Bayer AG 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Sales Footprint 22.3.1.4. Key Financials 22.3.1.5. SWOT Analysis 22.3.1.6. Strategic Overview 22.3.2. Boehringer Ingelheim GmbH 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Sales Footprint 22.3.2.4. Key Financials 22.3.2.5. SWOT Analysis 22.3.2.6. Strategic Overview 22.3.3. Zoetis, Inc. 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Sales Footprint 22.3.3.4. Key Financials 22.3.3.5. SWOT Analysis 22.3.3.6. Strategic Overview 22.3.4. Ceva Santé Animale 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Sales Footprint 22.3.4.4. Key Financials 22.3.4.5. SWOT Analysis 22.3.4.6. Strategic Overview 22.3.5. Dechra Pharmaceuticals PLC 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Sales Footprint 22.3.5.4. Key Financials 22.3.5.5. SWOT Analysis 22.3.5.6. Strategic Overview 22.3.6. Elanco Animal Health (Sub. Eli Lilly) 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Sales Footprint 22.3.6.4. Key Financials 22.3.6.5. SWOT Analysis 22.3.6.6. Strategic Overview 22.3.7. Merck Animal Health 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Sales Footprint 22.3.7.4. Key Financials 22.3.7.5. SWOT Analysis 22.3.7.6. Strategic Overview 22.3.8. Virbac SA 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Sales Footprint 22.3.8.4. Key Financials 22.3.8.5. SWOT Analysis 22.3.8.6. Strategic Overview 22.3.9. Vetoquinol SA 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Sales Footprint 22.3.9.4. Key Financials 22.3.9.5. SWOT Analysis 22.3.9.6. Strategic Overview 22.3.10. Intas Animal Health 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Sales Footprint 22.3.10.4. Key Financials 22.3.10.5. SWOT Analysis 22.3.10.6. Strategic Overview 22.3.11. Alembic Animal Health 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Sales Footprint 22.3.11.4. Key Financials 22.3.11.5. SWOT Analysis 22.3.11.6. Strategic Overview 22.3.12. Sequent Scientific 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Sales Footprint 22.3.12.4. Key Financials 22.3.12.5. SWOT Analysis 22.3.12.6. Strategic Overview 22.3.13. Hester Biosciences 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Sales Footprint 22.3.13.4. Key Financials 22.3.13.5. SWOT Analysis 22.3.13.6. Strategic Overview 22.3.14. Ashish Life Sciences 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Sales Footprint 22.3.14.4. Key Financials 22.3.14.5. SWOT Analysis 22.3.14.6. Strategic Overview 22.3.15. Ouro Fino Saude Animal (Ourofino) 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Sales Footprint 22.3.15.4. Key Financials 22.3.15.5. SWOT Analysis 22.3.15.6. Strategic Overview 22.3.16. Zydus Animal Health (Sub. Cadila Healthcare Ltd) 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Sales Footprint 22.3.16.4. Key Financials 22.3.16.5. SWOT Analysis 22.3.16.6. Strategic Overview 22.3.17. Phibro Animal Health Corporation 22.3.17.1. Overview 22.3.17.2. Product Portfolio 22.3.17.3. Sales Footprint 22.3.17.4. Key Financials 22.3.17.5. SWOT Analysis 22.3.17.6. Strategic Overview 22.3.18. Nippon Zenyaku Kogyo Co., Ltd 22.3.18.1. Overview 22.3.18.2. Product Portfolio 22.3.18.3. Sales Footprint 22.3.18.4. Key Financials 22.3.18.5. SWOT Analysis 22.3.18.6. Strategic Overview 22.3.19. Norbrook 22.3.19.1. Overview 22.3.19.2. Product Portfolio 22.3.19.3. Sales Footprint 22.3.19.4. Key Financials 22.3.19.5. SWOT Analysis 22.3.19.6. Strategic Overview 22.3.20. Kyoritsu Seiyaku Corporation 22.3.20.1. Overview 22.3.20.2. Product Portfolio 22.3.20.3. Sales Footprint 22.3.20.4. Key Financials 22.3.20.5. SWOT Analysis 22.3.20.6. Strategic Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Billion) Forecast by Region, 2012 to 2032 Table 2: Global Market Value (US$ Billion) Forecast by Product, 2012 to 2032 Table 3: Global Market Value (US$ Billion) Forecast by Animal, 2012 to 2032 Table 4: Global Market Value (US$ Billion) Forecast by Route of Administration, 2012 to 2032 Table 5: Global Market Value (US$ Billion) Forecast by Distribution Channel, 2012 to 2032 Table 6: North America Market Value (US$ Billion) Forecast by Country, 2012 to 2032 Table 7: North America Market Value (US$ Billion) Forecast by Product, 2012 to 2032 Table 8: North America Market Value (US$ Billion) Forecast by Animal, 2012 to 2032 Table 9: North America Market Value (US$ Billion) Forecast by Route of Administration, 2012 to 2032 Table 10: North America Market Value (US$ Billion) Forecast by Distribution Channel, 2012 to 2032 Table 11: Latin America Market Value (US$ Billion) Forecast by Country, 2012 to 2032 Table 12: Latin America Market Value (US$ Billion) Forecast by Product, 2012 to 2032 Table 13: Latin America Market Value (US$ Billion) Forecast by Animal, 2012 to 2032 Table 14: Latin America Market Value (US$ Billion) Forecast by Route of Administration, 2012 to 2032 Table 15: Latin America Market Value (US$ Billion) Forecast by Distribution Channel, 2012 to 2032 Table 16: Europe Market Value (US$ Billion) Forecast by Country, 2012 to 2032 Table 17: Europe Market Value (US$ Billion) Forecast by Product, 2012 to 2032 Table 18: Europe Market Value (US$ Billion) Forecast by Animal, 2012 to 2032 Table 19: Europe Market Value (US$ Billion) Forecast by Route of Administration, 2012 to 2032 Table 20: Europe Market Value (US$ Billion) Forecast by Distribution Channel, 2012 to 2032 Table 21: East Asia Market Value (US$ Billion) Forecast by Country, 2012 to 2032 Table 22: East Asia Market Value (US$ Billion) Forecast by Product, 2012 to 2032 Table 23: East Asia Market Value (US$ Billion) Forecast by Animal, 2012 to 2032 Table 24: East Asia Market Value (US$ Billion) Forecast by Route of Administration, 2012 to 2032 Table 25: East Asia Market Value (US$ Billion) Forecast by Distribution Channel, 2012 to 2032 Table 26: South Asia Market Value (US$ Billion) Forecast by Country, 2012 to 2032 Table 27: South Asia Market Value (US$ Billion) Forecast by Product, 2012 to 2032 Table 28: South Asia Market Value (US$ Billion) Forecast by Animal, 2012 to 2032 Table 29: South Asia Market Value (US$ Billion) Forecast by Route of Administration, 2012 to 2032 Table 30: South Asia Market Value (US$ Billion) Forecast by Distribution Channel, 2012 to 2032 Table 31: Oceania Market Value (US$ Billion) Forecast by Country, 2012 to 2032 Table 32: Oceania Market Value (US$ Billion) Forecast by Product, 2012 to 2032 Table 33: Oceania Market Value (US$ Billion) Forecast by Animal, 2012 to 2032 Table 34: Oceania Market Value (US$ Billion) Forecast by Route of Administration, 2012 to 2032 Table 35: Oceania Market Value (US$ Billion) Forecast by Distribution Channel, 2012 to 2032 Table 36: MEA Market Value (US$ Billion) Forecast by Country, 2012 to 2032 Table 37: MEA Market Value (US$ Billion) Forecast by Product, 2012 to 2032 Table 38: MEA Market Value (US$ Billion) Forecast by Animal, 2012 to 2032 Table 39: MEA Market Value (US$ Billion) Forecast by Route of Administration, 2012 to 2032 Table 40: MEA Market Value (US$ Billion) Forecast by Distribution Channel, 2012 to 2032
Figure 1: Global Market Value (US$ Billion) by Product, 2022 to 2032 Figure 2: Global Market Value (US$ Billion) by Animal, 2022 to 2032 Figure 3: Global Market Value (US$ Billion) by Route of Administration, 2022 to 2032 Figure 4: Global Market Value (US$ Billion) by Distribution Channel, 2022 to 2032 Figure 5: Global Market Value (US$ Billion) by Region, 2022 to 2032 Figure 6: Global Market Value (US$ Billion) Analysis by Region, 2012 to 2032 Figure 7: Global Market Value Share (%) Analysis by Region, 2022 to 2032 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032 Figure 9: Global Market Value (US$ Billion) Analysis by Product, 2012 to 2032 Figure 10: Global Market Value Share (%) Analysis by Product, 2022 to 2032 Figure 11: Global Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032 Figure 12: Global Market Value (US$ Billion) Analysis by Animal, 2012 to 2032 Figure 13: Global Market Value Share (%) Analysis by Animal, 2022 to 2032 Figure 14: Global Market Y-o-Y Growth (%) Projections by Animal, 2022 to 2032 Figure 15: Global Market Value (US$ Billion) Analysis by Route of Administration, 2012 to 2032 Figure 16: Global Market Value Share (%) Analysis by Route of Administration, 2022 to 2032 Figure 17: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2032 Figure 18: Global Market Value (US$ Billion) Analysis by Distribution Channel, 2012 to 2032 Figure 19: Global Market Value Share (%) Analysis by Distribution Channel, 2022 to 2032 Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 21: Global Market Attractiveness by Product, 2022 to 2032 Figure 22: Global Market Attractiveness by Animal, 2022 to 2032 Figure 23: Global Market Attractiveness by Route of Administration, 2022 to 2032 Figure 24: Global Market Attractiveness by Distribution Channel, 2022 to 2032 Figure 25: Global Market Attractiveness by Region, 2022 to 2032 Figure 26: North America Market Value (US$ Billion) by Product, 2022 to 2032 Figure 27: North America Market Value (US$ Billion) by Animal, 2022 to 2032 Figure 28: North America Market Value (US$ Billion) by Route of Administration, 2022 to 2032 Figure 29: North America Market Value (US$ Billion) by Distribution Channel, 2022 to 2032 Figure 30: North America Market Value (US$ Billion) by Country, 2022 to 2032 Figure 31: North America Market Value (US$ Billion) Analysis by Country, 2012 to 2032 Figure 32: North America Market Value Share (%) Analysis by Country, 2022 to 2032 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 34: North America Market Value (US$ Billion) Analysis by Product, 2012 to 2032 Figure 35: North America Market Value Share (%) Analysis by Product, 2022 to 2032 Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032 Figure 37: North America Market Value (US$ Billion) Analysis by Animal, 2012 to 2032 Figure 38: North America Market Value Share (%) Analysis by Animal, 2022 to 2032 Figure 39: North America Market Y-o-Y Growth (%) Projections by Animal, 2022 to 2032 Figure 40: North America Market Value (US$ Billion) Analysis by Route of Administration, 2012 to 2032 Figure 41: North America Market Value Share (%) Analysis by Route of Administration, 2022 to 2032 Figure 42: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 43: North America Market Value (US$ Billion) Analysis by Distribution Channel, 2012 to 2032 Figure 44: North America Market Value Share (%) Analysis by Distribution Channel, 2022 to 2032 Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 46: North America Market Attractiveness by Product, 2022 to 2032 Figure 47: North America Market Attractiveness by Animal, 2022 to 2032 Figure 48: North America Market Attractiveness by Route of Administration, 2022 to 2032 Figure 49: North America Market Attractiveness by Distribution Channel, 2022 to 2032 Figure 50: North America Market Attractiveness by Country, 2022 to 2032 Figure 51: Latin America Market Value (US$ Billion) by Product, 2022 to 2032 Figure 52: Latin America Market Value (US$ Billion) by Animal, 2022 to 2032 Figure 53: Latin America Market Value (US$ Billion) by Route of Administration, 2022 to 2032 Figure 54: Latin America Market Value (US$ Billion) by Distribution Channel, 2022 to 2032 Figure 55: Latin America Market Value (US$ Billion) by Country, 2022 to 2032 Figure 56: Latin America Market Value (US$ Billion) Analysis by Country, 2012 to 2032 Figure 57: Latin America Market Value Share (%) Analysis by Country, 2022 to 2032 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 59: Latin America Market Value (US$ Billion) Analysis by Product, 2012 to 2032 Figure 60: Latin America Market Value Share (%) Analysis by Product, 2022 to 2032 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032 Figure 62: Latin America Market Value (US$ Billion) Analysis by Animal, 2012 to 2032 Figure 63: Latin America Market Value Share (%) Analysis by Animal, 2022 to 2032 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Animal, 2022 to 2032 Figure 65: Latin America Market Value (US$ Billion) Analysis by Route of Administration, 2012 to 2032 Figure 66: Latin America Market Value Share (%) Analysis by Route of Administration, 2022 to 2032 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2032 Figure 68: Latin America Market Value (US$ Billion) Analysis by Distribution Channel, 2012 to 2032 Figure 69: Latin America Market Value Share (%) Analysis by Distribution Channel, 2022 to 2032 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 71: Latin America Market Attractiveness by Product, 2022 to 2032 Figure 72: Latin America Market Attractiveness by Animal, 2022 to 2032 Figure 73: Latin America Market Attractiveness by Route of Administration, 2022 to 2032 Figure 74: Latin America Market Attractiveness by Distribution Channel, 2022 to 2032 Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032 Figure 76: Europe Market Value (US$ Billion) by Product, 2022 to 2032 Figure 77: Europe Market Value (US$ Billion) by Animal, 2022 to 2032 Figure 78: Europe Market Value (US$ Billion) by Route of Administration, 2022 to 2032 Figure 79: Europe Market Value (US$ Billion) by Distribution Channel, 2022 to 2032 Figure 80: Europe Market Value (US$ Billion) by Country, 2022 to 2032 Figure 81: Europe Market Value (US$ Billion) Analysis by Country, 2012 to 2032 Figure 82: Europe Market Value Share (%) Analysis by Country, 2022 to 2032 Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 84: Europe Market Value (US$ Billion) Analysis by Product, 2012 to 2032 Figure 85: Europe Market Value Share (%) Analysis by Product, 2022 to 2032 Figure 86: Europe Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032 Figure 87: Europe Market Value (US$ Billion) Analysis by Animal, 2012 to 2032 Figure 88: Europe Market Value Share (%) Analysis by Animal, 2022 to 2032 Figure 89: Europe Market Y-o-Y Growth (%) Projections by Animal, 2022 to 2032 Figure 90: Europe Market Value (US$ Billion) Analysis by Route of Administration, 2012 to 2032 Figure 91: Europe Market Value Share (%) Analysis by Route of Administration, 2022 to 2032 Figure 92: Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2032 Figure 93: Europe Market Value (US$ Billion) Analysis by Distribution Channel, 2012 to 2032 Figure 94: Europe Market Value Share (%) Analysis by Distribution Channel, 2022 to 2032 Figure 95: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 96: Europe Market Attractiveness by Product, 2022 to 2032 Figure 97: Europe Market Attractiveness by Animal, 2022 to 2032 Figure 98: Europe Market Attractiveness by Route of Administration, 2022 to 2032 Figure 99: Europe Market Attractiveness by Distribution Channel, 2022 to 2032 Figure 100: Europe Market Attractiveness by Country, 2022 to 2032 Figure 101: East Asia Market Value (US$ Billion) by Product, 2022 to 2032 Figure 102: East Asia Market Value (US$ Billion) by Animal, 2022 to 2032 Figure 103: East Asia Market Value (US$ Billion) by Route of Administration, 2022 to 2032 Figure 104: East Asia Market Value (US$ Billion) by Distribution Channel, 2022 to 2032 Figure 105: East Asia Market Value (US$ Billion) by Country, 2022 to 2032 Figure 106: East Asia Market Value (US$ Billion) Analysis by Country, 2012 to 2032 Figure 107: East Asia Market Value Share (%) Analysis by Country, 2022 to 2032 Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 109: East Asia Market Value (US$ Billion) Analysis by Product, 2012 to 2032 Figure 110: East Asia Market Value Share (%) Analysis by Product, 2022 to 2032 Figure 111: East Asia Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032 Figure 112: East Asia Market Value (US$ Billion) Analysis by Animal, 2012 to 2032 Figure 113: East Asia Market Value Share (%) Analysis by Animal, 2022 to 2032 Figure 114: East Asia Market Y-o-Y Growth (%) Projections by Animal, 2022 to 2032 Figure 115: East Asia Market Value (US$ Billion) Analysis by Route of Administration, 2012 to 2032 Figure 116: East Asia Market Value Share (%) Analysis by Route of Administration, 2022 to 2032 Figure 117: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2032 Figure 118: East Asia Market Value (US$ Billion) Analysis by Distribution Channel, 2012 to 2032 Figure 119: East Asia Market Value Share (%) Analysis by Distribution Channel, 2022 to 2032 Figure 120: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 121: East Asia Market Attractiveness by Product, 2022 to 2032 Figure 122: East Asia Market Attractiveness by Animal, 2022 to 2032 Figure 123: East Asia Market Attractiveness by Route of Administration, 2022 to 2032 Figure 124: East Asia Market Attractiveness by End user, 2022 to 2032 Figure 125: East Asia Market Attractiveness by Country, 2022 to 2032 Figure 126: South Asia Market Value (US$ Billion) by Product, 2022 to 2032 Figure 127: South Asia Market Value (US$ Billion) by Animal, 2022 to 2032 Figure 128: South Asia Market Value (US$ Billion) by Route of Administration, 2022 to 2032 Figure 129: South Asia Market Value (US$ Billion) by Distribution Channel, 2022 to 2032 Figure 130: South Asia Market Value (US$ Billion) by Country, 2022 to 2032 Figure 131: South Asia Market Value (US$ Billion) Analysis by Country, 2012 to 2032 Figure 132: South Asia Market Value Share (%) Analysis by Country, 2022 to 2032 Figure 133: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 134: South Asia Market Value (US$ Billion) Analysis by Product, 2012 to 2032 Figure 135: South Asia Market Value Share (%) Analysis by Product, 2022 to 2032 Figure 136: South Asia Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032 Figure 137: South Asia Market Value (US$ Billion) Analysis by Animal, 2012 to 2032 Figure 138: South Asia Market Value Share (%) Analysis by Animal, 2022 to 2032 Figure 139: South Asia Market Y-o-Y Growth (%) Projections by Animal, 2022 to 2032 Figure 140: South Asia Market Value (US$ Billion) Analysis by Route of Administration, 2012 to 2032 Figure 141: South Asia Market Value Share (%) Analysis by Route of Administration, 2022 to 2032 Figure 142: South Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2032 Figure 143: South Asia Market Value (US$ Billion) Analysis by Distribution Channel, 2012 to 2032 Figure 144: South Asia Market Value Share (%) Analysis by Distribution Channel, 2022 to 2032 Figure 145: South Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 146: South Asia Market Attractiveness by Product, 2022 to 2032 Figure 147: South Asia Market Attractiveness by Animal, 2022 to 2032 Figure 148: South Asia Market Attractiveness by Route of Administration, 2022 to 2032 Figure 149: South Asia Market Attractiveness by Distribution Channel, 2022 to 2032 Figure 150: South Asia Market Attractiveness by Country, 2022 to 2032 Figure 151: Oceania Market Value (US$ Billion) by Product, 2022 to 2032 Figure 152: Oceania Market Value (US$ Billion) by Animal, 2022 to 2032 Figure 153: Oceania Market Value (US$ Billion) by Route of Administration, 2022 to 2032 Figure 154: Oceania Market Value (US$ Billion) by Distribution Channel, 2022 to 2032 Figure 155: Oceania Market Value (US$ Billion) by Country, 2022 to 2032 Figure 156: Oceania Market Value (US$ Billion) Analysis by Country, 2012 to 2032 Figure 157: Oceania Market Value Share (%) Analysis by Country, 2022 to 2032 Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 159: Oceania Market Value (US$ Billion) Analysis by Product, 2012 to 2032 Figure 160: Oceania Market Value Share (%) Analysis by Product, 2022 to 2032 Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032 Figure 162: Oceania Market Value (US$ Billion) Analysis by Animal, 2012 to 2032 Figure 163: Oceania Market Value Share (%) Analysis by Animal, 2022 to 2032 Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Animal, 2022 to 2032 Figure 165: Oceania Market Value (US$ Billion) Analysis by Route of Administration, 2012 to 2032 Figure 166: Oceania Market Value Share (%) Analysis by Route of Administration, 2022 to 2032 Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2032 Figure 168: Oceania Market Value (US$ Billion) Analysis by Distribution Channel, 2012 to 2032 Figure 169: Oceania Market Value Share (%) Analysis by Distribution Channel, 2022 to 2032 Figure 170: Oceania Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 171: Oceania Market Attractiveness by Product, 2022 to 2032 Figure 172: Oceania Market Attractiveness by Animal, 2022 to 2032 Figure 173: Oceania Market Attractiveness by Route of Administration, 2022 to 2032 Figure 174: Oceania Market Attractiveness by Distribution Channel, 2022 to 2032 Figure 175: Oceania Market Attractiveness by Country, 2022 to 2032 Figure 176: MEA Market Value (US$ Billion) by Product, 2022 to 2032 Figure 177: MEA Market Value (US$ Billion) by Animal, 2022 to 2032 Figure 178: MEA Market Value (US$ Billion) by Route of Administration, 2022 to 2032 Figure 179: MEA Market Value (US$ Billion) by Distribution Channel, 2022 to 2032 Figure 180: MEA Market Value (US$ Billion) by Country, 2022 to 2032 Figure 181: MEA Market Value (US$ Billion) Analysis by Country, 2012 to 2032 Figure 182: MEA Market Value Share (%) Analysis by Country, 2022 to 2032 Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 184: MEA Market Value (US$ Billion) Analysis by Product, 2012 to 2032 Figure 185: MEA Market Value Share (%) Analysis by Product, 2022 to 2032 Figure 186: MEA Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032 Figure 187: MEA Market Value (US$ Billion) Analysis by Animal, 2012 to 2032 Figure 188: MEA Market Value Share (%) Analysis by Animal, 2022 to 2032 Figure 189: MEA Market Y-o-Y Growth (%) Projections by Animal, 2022 to 2032 Figure 190: MEA Market Value (US$ Billion) Analysis by Route of Administration, 2012 to 2032 Figure 191: MEA Market Value Share (%) Analysis by Route of Administration, 2022 to 2032 Figure 192: MEA Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2032 Figure 193: MEA Market Value (US$ Billion) Analysis by Distribution Channel, 2012 to 2032 Figure 194: MEA Market Value Share (%) Analysis by Distribution Channel, 2022 to 2032 Figure 195: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032 Figure 196: MEA Market Attractiveness by Product, 2022 to 2032 Figure 197: MEA Market Attractiveness by Animal, 2022 to 2032 Figure 198: MEA Market Attractiveness by Route of Administration, 2022 to 2032 Figure 199: MEA Market Attractiveness by Distribution Channel, 2022 to 2032 Figure 200: MEA Market Attractiveness by Country, 2022 to 2032
Recommendations
Explore Healthcare Insights
View Reports